Science Explorer Back to mapMap
Discussion
Topic · Genetics

Neurogenetic and Muscular Disorders Research

Neurogenetic and Muscular Disorders Research is a research topic within Genetics. Science Explorer counts 25k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the gene therapy, molecular genetics, and clinical management of Spinal Muscular Atrophy (SMA). It covers topics such as SMN1 and SMN2 genes, Nusinersen treatment, antisense oligonucleotide therapies, motor neuron pathology, and the role of survival motor neuron protein in SMA. The cluster also discusses potential therapeutic strategies, including gene replacement therapy and the use of small molecules to modulate SMN expression.

  • Spinal Muscular Atrophy
  • SMN1
  • Nusinersen
  • Gene Replacement Therapy
  • Motor Neuron
  • SMN2
  • Antisense Oligonucleotides
  • Neuromuscular Junction
  • Survival Motor Neuron Protein
  • Clinical Management
Research works
25k
fractional, since 1950
In the world top 10%
2.5k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+9%
the tick is no change
Largest producer
United States
34% of the 10 largest, 2022-now
Neurogenetic and Muscular Disorders Research

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Neurogenetic and Muscular Disorders Research research?

By volume, the United States and China publish the most (1.2k and 541 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.2k works
  2. 2 China 541 works
  3. 3 United Kingdom 344 works
  4. 4 Italy 326 works
  5. 5 India 249 works
  6. 6 Germany 239 works
  7. 7 Japan 226 works
  8. 8 France 191 works
  9. 9 Canada 165 works
  10. 10 Brazil 160 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 33.6%China: 14.7%United Kingdom: 9.4%Italy: 8.9%6 others listed: 33.5%34%largest
United States1,234 · 33.6%China541 · 14.7%United Kingdom344 · 9.4%Italy326 · 8.9%6 others listed1,230 · 33.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Neurogenetic and Muscular Disorders Research research?

By volume in 2022-now, University College London publishes the most Neurogenetic and Muscular Disorders Research research, followed by Harvard University and Inserm.

Who are the leading researchers in Neurogenetic and Muscular Disorders Research?

The most-cited researchers publishing on Neurogenetic and Muscular Disorders Research include Mark J. Daly, Stacey L. Gabriel and Shizuo Akira.

  1. 1 Mark J. Daly United States 403k citations
  2. 2 Stacey L. Gabriel United States 402k citations
  3. 3 Shizuo Akira Japan 342k citations
  4. 4 Cyrus Cooper United Kingdom 342k citations
  5. 5 Valery L. Feigin New Zealand 341k citations
  6. 6 Jun Wang China 340k citations
  7. 7 Gregory Y.H. Lip United Kingdom 311k citations
  8. 8 Matthias Mann Germany 308k citations
  9. 9 Gonçalo R. Abecasis United States 300k citations
  10. 10 Naohiro Yonemoto Japan 297k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Neurogenetic and Muscular Disorders Research?

The most cited paper in Neurogenetic and Muscular Disorders Research is "Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS" (Mariely DeJesus‐Hernandez et al., 2011), with 5,066 citations. Next come "A report: the definition and classification of cerebral palsy April 2006" (4,833) and "A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD" (4,545).

Most cited papers
#PaperReleasedCitations
1 Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS Mariely DeJesus‐Hernandez et al. · Neuron Open access 21 Sep 2011 5,066
2 A report: the definition and classification of cerebral palsy April 2006 Peter Rosenbaum, Nigel Paneth, Alan Edward Leviton et al. · Developmental Medicine & Child Neurology Open access Feb 2007 4,833
3 A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD Alan Edward Renton et al. · Neuron Open access 22 Sep 2011 4,545
4 Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation Mark E. Gurney, Haifeng Pu, Arlene Y. Chiu et al. · Science 17 Jun 1994 4,179
5 Identification and characterization of a spinal muscular atrophy-determining gene Suzie Lefebvre, Lydie Bürglen, Sophie Reboullet et al. · Cell Open access 1995 4,053
All 100 most cited papers, with filters and sorting

Where is Neurogenetic and Muscular Disorders Research research done?

The largest centres of Neurogenetic and Muscular Disorders Research research in 2022-now are London (United Kingdom), Beijing (China), Paris (France) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Basel and Sheffield.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 135 works
  2. 2 BeijingChina 95 works
  3. 3 ParisFrance 89 works
  4. 4 TokyoJapan 72 works
  5. 5 MilanItaly 66 works
  6. 6 RomeItaly 60 works
  7. 7 New YorkUnited States 60 works
  8. 8 BostonUnited States 55 works
  9. 9 SeoulSouth Korea 47 works
  10. 10 ShanghaiChina 44 works

Where it is the local speciality

  1. BaselCH · 23.2 works7.4×
  2. SheffieldGB · 25.5 works7.1×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Neurogenetic and Muscular Disorders Research than the world average.

See Neurogenetic and Muscular Disorders Research on the map

Where is the best place to study Neurogenetic and Muscular Disorders Research?

Among universities, judged by research, University College London, KU Leuven and Harvard University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.53%fractional works in this field (log) →share of work in the world top 10% →KU LeuvenUniversity College L…Utrecht UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University College LondonUnited Kingdom 71.917.2%8.1×58 -12.8%
2KU LeuvenBelgium 66.728.6%4.5×20 -15.7%
3Harvard UniversityUnited States 66.514.6%3.6×52 -10.7%
4Utrecht UniversityNetherlands 65.215.0%7.3×24 +13.7%
5University of SheffieldUnited Kingdom 63.416.1%7.6×18 +29.3%
6Johns Hopkins UniversityUnited States 63.121.5%3.5×24 -15.6%
7University of Massachusetts Chan Medical SchoolUnited States 62.325.5%14.2×11 +1.8%
8Karolinska InstitutetSweden 60.422.9%4.8×12 +9.7%
9Heidelberg UniversityGermany 60.327.3%3.6×12 +38.9%
10McGill UniversityCanada 59.56.6%7.2×33 +47.6%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Neurogenetic and Muscular Disorders Research, country by country

Is Neurogenetic and Muscular Disorders Research research growing?

Output in 2022-2025 was 9% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Neurogenetic and Muscular Disorders Research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Neurogenetic and Muscular Disorders Research as a percentage of every work published that year, 0.022% in 2024.

still counting0.020%0.040%Neurogenetic and Muscular Disorders Research0.022% in 202519801990200020102020

Fractional works of Neurogenetic and Muscular Disorders Research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Neurogenetic and Muscular Disorders Research9.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Neurogenetic and Muscular Disorders Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.